Table 1. Inhibitory Potencies of the Parent, Precursors, and Bivalent Ligands at hNaV1.4 and hNaV1.7a.
| Ligand | IC50 (nM ± SEM) | IC50 relative to 1 | n | |
|---|---|---|---|---|
| hNaV1.4 | ||||
| Bivalent ligands | ||||
| 1 | [m3-HwTx-IV]-[PEG80]-[K-KIIIA] | 9 ± 1 | 1 | 3 |
| 2 | [m3-HwTx-IV]-[PEG60]-[K-KIIIA] | 14 ± 1 | 1.6× ↑ | 3 |
| 3 | [m3-HwTx-IV]-[PEG120]-[K-KIIIA] | 13 ± 3 | 1.4× ↑ | 3 |
| Controls | ||||
| 4 | [m3-HwTx-IV]-[PEG40]-[K-KIIIA] | 29 ± 5 | 3.2× ↑ | 4 |
| 5 | AzK-KIIIA/S-m3-HwTx-IV | 33 ± 8 | 3.7× ↑ | 3 |
| 6 | AzK-KIIIA | 32 ± 10 | 3.6× ↑ | 3 |
| 7 | μ-KIIIA30 | 48 ± 6b | 5.3× ↑ | 3 |
| 8 | [K-KIIIA]-[PEG80] | 144 ± 46 | 16.0× ↑ | 4 |
| 9 | S-m3-HwTx-IV | 212 ± 20 | 23.6× ↑ | 4 |
| 10 | m3-HwTx-IV36 | 369 ± 196c | 41.0× ↑ | 6 |
| 11 | HwTx-IV49 | 400 ± nab | 44.4× ↑ | 3 |
| 12 | [m3-HwTx-IV]-[PEG80] | 409 ± 64 | 45.4× ↑ | 4 |
| hNaV1.7 | ||||
| Bivalent ligand | ||||
| 1 | [m3-HwTx-IV]-[PEG80]-[K-KIIIA] | 6 ± 0.1 | 1 | 3 |
| Controls | ||||
| 4 | [m3-HwTx-IV]-[PEG40]-[K-KIIIA] | 6 ± 2 | no change | 4 |
| 5 | AzK-KIIIA/S-m3-HwTx-IV | 6 ± 1 | no change | 3 |
| 6 | AzK-KIIIA | 96 ± 41 | 16.0× ↑ | 3 |
| 7 | μ-KIIIA | 132 ± 37 | 22.0× ↑ | 4 |
| 9 | S-m3-HwTx-IV | 4 ± 0.3 | 1.5x ↓ | 4 |
| 10 | m3-HwTx-IV34 | 0.4 ± 0.1 | 15.0× ↓ | 6 |
| 11 | HwTx-IV34 | 17 ± 2 | 2.8× ↑ | 10 |
| 12 | [m3-HwTx-IV]-[PEG80] | 8 ± 1 | 1.3× ↑ | 4 |
n is the number of cells, with each cell considered an independent experiment.
IC50 values were determined on rat NaV channel.
The IC50 value was determined for the peptide with no C-terminal amidation. Legend: n.a., not available; ↑, fold increase in IC50 relative to ligand 1; ↓, fold decrease in IC50 relative to ligand 1.